Article Le Monde: Delbert, saving essential medicines from dissapearing

Dec 2022

Article published on Lemonde.fr, December 2, 2022.

Since 2013, the pharmaceutical company has been fighting to breathe new life into essential old molecules threatened with disappearing from the therapeutic arsenal. With each new dossier that lands on its desk, the rule is always the same.

“We check that the medicine meets a clear medical need, then assess whether its development is technically feasible in France or Europe. If we’re 85% sure, we go ahead”, explains Thierry Hoffmann, Managing Director of Laboratoires Delbert.

READ MORE on lemonde.fr

Back to news

Delbert Pharma awarded Mission-driven company status

Sep 2023

Paris, 09/27/2023 Delbert Pharma, a major player in the safeguarding and relocation of essential medicines, is proud to announce that it has officially been awarded Mission-driven company status in September 2023. This recognition, the fruit of intense collaborative...

New investment in Laboratoires Delbert

Apr 2023

Vivalto Partners announces a significant investment in Laboratoires Delbert to support the company's development in the field of essential and orphan drugs. The historical investors - Sagard NewGen, Socadif Capital Investissement, IDIA Capital Investissement and MACSF...

Laboratoires Delbert signs the Supplier Relations and Purchasing Charter

Jan 2023

Laboratoires Delbert is pleased to announce that it has signed the Responsible Purchasing and Supplier Relations (RFAR) charter. Committed since its creation to responsible approaches with its suppliers, on January 23, 2023 Laboratoires Delbert formalized these...